Page 212 - ASHG 2013 Program Guide

POSTER SESSIONS
  199
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
2123
F Cross-sectional and longitudinal replication
analyses of genome-wide association loci of type 2
diabetes in Han Chinese populations.
Q. Zhao, X. Kong,
J. Hong, X. Zhang, J. He, W. Yang.
2124
W Sex-specific genetic variants on 11p15
influence high density-lipop otein cholesterol levels in
long-lived subjects: The Long Life Family Study.
M. F.
Feitosa, M. K. Wojczynski, C. M. Kammerer, W. Daw, R.
J. Straka, J. H. Lee, K. Christensen, A. B. Newman, M. A.
Province, I. B. Borecki.
2125
T Influence of genetic determinants and lifestyle
factors on blood lipid traits: 10-year follow-up of the
GLACIER Study.
T. V. Varga, D. Shungin, R. W. Koivula,
G. Hallmans, I. Johansson, I. Barroso, F. Renström, P. W.
Franks.
2126
F Haplotypes of cytokine gene polymorphisms
in dilated cardiomyopathy.
M. L. Satyanarayana, V.
Viswamitra, N. Swapna, N. Pratibha.
2127
W Multi-ethnic case-control studies of Moyamoya
disease by high-depth exome sequencing of unrelated
affected individuals and matched controls.
M. Clark, L.
Shoemaker, A. Patwardhan, R. Chen, G. Chandratillake,
S. Garcia, N. Leng, S. Chervitz, M. Pratt, H. Lam, D.
Newburger, S. Kirk, C. Haudenschild, J. West, R. Chen, G.
Steinberg.
2128
T Digenic inheritance of mutations in
ITGA7
and
MYH7B
results in congenital myopathy with left
ventricular non-compact cardiomyopathy.
T. Esposito,
S. Sampaolo, G. Limongelli, A. Varone, D. Formicola,
D. Diodato, O. Farina, F. Napolitano, G. Pacileo, F.
Gianfrancesco, G. Di Iorio.
2129
F Genetic variants associated with C-reactive
protein in African Americans: A MetaboChip analysis
in the Population Architecture using Genomics and
Epidemiology study.
J. M. Kocarnik, C. L. Carty, A.
Reiner, C. L. Avery, C. M. Ballantyne, J. Haessler, A.
LaCroix, A. Young, T. L. Assimes, M. Barbalic, W. Tang, L.
G. Best, J. L. Ambite, I. Cheng, L. A. Hindorff, G. Heiss, C.
A. Haiman, C. L. Kooperberg, L. Le Marchand, U. Peters.
2130
W Predictive profile for the early detection of
metabolic syndrome in a pediatric Turkish cohort.
M. J.
White, M. Agirbasli, F. Eren, D. Agirbasli, S. M. Williams.
2131
T Investigation of functional variants of eight
SNPs in lipid level modifier genes in healthy Roma and
Hungarian population.
B. Melegh, K. Sumegi, L. Jaromi,
L. Magyari, E. Kovesdi, B. Duga, R. Szalai, P. Matyas,
Zs. Banfai, A. Szabo, J. Bene.
2132
F Arterial tortuosity in patients with vascular
abnormalities due to mutation in filamin A
E. Reinstein,
S. Morris, D. Rimoin, R. Lacro.
2133
W Phenotype, genotype and natural history
of arrhythmogenic dilated cardiomyopathy.
A.
Spezzacatene, G. Sinagra, M. Merlo, G. Barbati, D. Slavov,
A. Di Lenarda, X. Zhu, S. Graw, E. Salcedo, M. Taylor, L.
Mestroni.
2111
F Replication of hypertension risk score in two
Hispanic populations.
G. Beecham, A. Beecham, N.
Vasudeva, L. Wang, Z. Liu, T. Rundek, P. Goldschmidt, M.
Pericak-Vance, D. Seo, R. L. Sacco, S. Blanton.
2112
W Role of the rs1704 HLA-G and rs2227631
PAI-1 polymorphisms in acute coronary syndrome.
I. J. Garcia-Gonzalez, Y. Valle, F. Rivas, L. E. Figuera-
Villanueva, J. F. Muñoz-Valle, F. Ortega-Gutiérrez, B.
E. Gutiérrez-Amavizca, N. O. Dávalos-Rodríguez, J. R.
Padilla-Gutiérrez.
2113
T
FLNA
mutations found in patients with aortic
aneurysm/dissections.
H. Morisaki, I. Yamanaka, A.
Yoshida, R. Sultana, K. Minatoya, I. Shiraishi, H. Ichikawa,
T. Kosho, H. Sonoda, T. Morisaki.
2114
F Arrhythmogenic right ventricular
cardiomyopathy-molecular analysis.
P. Nallari.
2115
W A variant in the 5-hydroxytryptamine receptor
1
A (
HTR1A
)
gene is associated with platelet reactivity
and incident cardiovascular events.
S. H. Shah, M.
A. Babyak, E. R. Hauser, D. Craig, M. Chryst-Ladd,
C. Haynes, B. Brumett, W. E. Kraus, R. Becker, R. B.
Williams.
2116
T Exome sequencing identifies
BAG3
gene
mutation in dilated cardiomyopathy.
M. Taylor, R. L.
Begay, V. D. Myers, S. L. Graw, D. Slavov, P. Boyer, L.
Mestroni, A. Feldman.
2117
F Haploinsufficiency of
RERE
contributes to
cardiovascular defects associated with 1p36 deletions.
H. Zaveri, B. J. Kim, A. Hernandez-Garcia, T. F. Beck, O. A.
Shchelochkov, M. Justice, B. Lee, S. R. Lalani, D. A. Scott.
2118
W Analysis of common and coding variants with
cardiovascular disease in the Diabetes Heart Study.
J.
N. Adams, L. M. Raffield, B. I. Freeman, C. D. Langefeld,
M. C. Y. Ng, J. J. Carr, A. J. Cox, D. W. Bowden.
2119
T
VKORC1
and
CALU
eQTLs and susceptibility to
venous thromboembolism among African Americans.
W. Hernandez, E. R. Gamazon, A. Konkashbaev, K.
Aquino-Michaels, T. J. O’Brien, A. F. Harralson, R. A.
Kittles, A. Barbour, M. Tuck, S. D. McIntosh, J. N. Douglas,
L. H. Cavallari, M. A. Perera.
2120
F Multi-allelic haplotype association identifie
a new protective haplotype in the
KCNN3
gene
for post-operative atrial fibrillation
M. Heydarpour,
C. Collard, A. Fox, J. Muehlschlegel, M. Sigurdsson,
S. Shernan, S. Body.
2121
W Elucidating the role of genes encoding
sarcomeric structural proteins in modulating cardiac
hypertrophy in hypertrophic cardiomyopathy.
C. J.
Kinnear, L. Bloem, L. van der Merwe, M. Revera, M.
Heradien, A. Goosen, P. A. Brink, J. C. Moolman-Smook.
2122
T Analysis of coding variants in C1q/TNF
superfamily genes in the Diabetes Heart Study.
L. M.
Raffield, A. J. Cox, C. D. Langefeld, M. C. Y. Ng, J. J. Carr,
B. I. Freedman, D. W. Bowden.